These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7676270)

  • 1. Tuberculosis--fighting a losing battle?
    Tan KK
    Singapore Med J; 1995 Apr; 36(2):209-11. PubMed ID: 7676270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Causes and factors of development of drug resistance in pulmonary tuberculosis].
    Nechaeva OB; Skachkova EI
    Probl Tuberk Bolezn Legk; 2003; (9):6-9. PubMed ID: 14598516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The epidemiology of tuberculosis and of the resistance to antitubercular agents].
    Aït Khaled N; Enarson D; Billo N
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S8-18. PubMed ID: 9496587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIAID describes research priorities for fighting drug-resistant tuberculosis.
    Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges of tuberculosis control.
    Murray S
    CMAJ; 2006 Jan; 174(1):33-4. PubMed ID: 16389233
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis.
    Garner P; Holmes A; Ziganshina L
    Clin Evid; 2004 Jun; (11):1081-93. PubMed ID: 15652053
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
    García-García ML; Sifuentes-Osornio J; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Bobadilla-del Valle M; Palacios-Martínez M; Canales G; Sanginés A; Jaramillo Y; Martínez-Gamboa A; Balandrano S; Valdespino-Gómez JL; Small P
    Rev Invest Clin; 2001; 53(4):315-23. PubMed ID: 11599478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis.
    Garner P; Holmes A; Ziganshina L
    Clin Evid; 2005 Dec; (14):1026-37. PubMed ID: 16620446
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance in tuberculosis].
    Winje BA; Mannsåker T; Langeland N; Heldal E
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis reemerges: the captain remains aboard.
    Efferen LS; Hyman CL
    Curr Opin Pulm Med; 1996 May; 2(3):236-45. PubMed ID: 9363145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Health Organization fact sheet. Tuberculosis.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis.
    Blomberg B; Spinaci S; Fourie B; Laing R
    Bull World Health Organ; 2001; 79(1):61-8. PubMed ID: 11217670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP
    Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
    Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.